Enliven Therapeutics Down Nearly 18%, on Pace for Largest Percent Decrease Since April 2022 -- Data Talk

Dow Jones11-04

Enliven Therapeutics, Inc. $(ELVN)$ is currently at $19.27, down $4.15 or 17.72%

--Would be lowest close since Sept. 25, 2025, when it closed at $18.57

--On pace for largest percent decrease since April 5, 2022, when it fell 22.09%

--Currently down two consecutive days; down 19.61% over this period

--Worst two-day stretch since the two days ending April 6, 2022, when it fell 31.29%

--Down 14.36% year-to-date; on pace for worst year since 2023, when it fell 15.4%

--Down 91.22% from its all-time closing high of $219.48 on June 11, 2020

--Down 30.31% from 52 weeks ago (Nov. 4, 2024), when it closed at $27.65

--Down 34.79% from its 52-week closing high of $29.55 on Nov. 6, 2024

--Up 29.24% from its 52-week closing low of $14.91 on April 10, 2025

--Traded as low as $18.33; lowest intraday level since Sept. 26, 2025, when it hit $18.28

--Down 21.73% at today's intraday low; largest intraday percent decrease since April 5, 2022, when it fell as much as 37.42%

All data as of 2:34:32 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 03, 2025 14:36 ET (19:36 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2580242862?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 03:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580242862","market":"sh","top_or_hot":-1,"title":"Enliven Therapeutics Down Nearly 18%, on Pace for Largest Percent Decrease Since April 2022 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Enliven <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Inc. <a href=\"https://laohu8.com/S/ELVN\">$(ELVN)$</a> is currently at $19.27, down $4.15 or 17.72% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Sept. 25, 2025, when it closed at $18.57 \n</p>\n<p>\n     --On pace for largest percent decrease since April 5, 2022, when it fell 22.09% \n</p>\n<p>\n     --Currently down two consecutive days; down 19.61% over this period \n</p>\n<p>\n     --Worst two-day stretch since the two days ending April 6, 2022, when it fell 31.29% \n</p>\n<p>\n     --Down 14.36% year-to-date; on pace for worst year since 2023, when it fell 15.4% \n</p>\n<p>\n     --Down 91.22% from its all-time closing high of $219.48 on June 11, 2020 \n</p>\n<p>\n     --Down 30.31% from 52 weeks ago (Nov. 4, 2024), when it closed at $27.65 \n</p>\n<p>\n     --Down 34.79% from its 52-week closing high of $29.55 on Nov. 6, 2024 \n</p>\n<p>\n     --Up 29.24% from its 52-week closing low of $14.91 on April 10, 2025 \n</p>\n<p>\n     --Traded as low as $18.33; lowest intraday level since Sept. 26, 2025, when it hit $18.28 \n</p>\n<p>\n     --Down 21.73% at today's intraday low; largest intraday percent decrease since April 5, 2022, when it fell as much as 37.42% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 2:34:32 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 03, 2025 14:36 ET (19:36 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Enliven Therapeutics Down Nearly 18%, on Pace for Largest Percent Decrease Since April 2022 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnliven Therapeutics Down Nearly 18%, on Pace for Largest Percent Decrease Since April 2022 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-04 03:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Enliven <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Inc. <a href=\"https://laohu8.com/S/ELVN\">$(ELVN)$</a> is currently at $19.27, down $4.15 or 17.72% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Sept. 25, 2025, when it closed at $18.57 \n</p>\n<p>\n     --On pace for largest percent decrease since April 5, 2022, when it fell 22.09% \n</p>\n<p>\n     --Currently down two consecutive days; down 19.61% over this period \n</p>\n<p>\n     --Worst two-day stretch since the two days ending April 6, 2022, when it fell 31.29% \n</p>\n<p>\n     --Down 14.36% year-to-date; on pace for worst year since 2023, when it fell 15.4% \n</p>\n<p>\n     --Down 91.22% from its all-time closing high of $219.48 on June 11, 2020 \n</p>\n<p>\n     --Down 30.31% from 52 weeks ago (Nov. 4, 2024), when it closed at $27.65 \n</p>\n<p>\n     --Down 34.79% from its 52-week closing high of $29.55 on Nov. 6, 2024 \n</p>\n<p>\n     --Up 29.24% from its 52-week closing low of $14.91 on April 10, 2025 \n</p>\n<p>\n     --Traded as low as $18.33; lowest intraday level since Sept. 26, 2025, when it hit $18.28 \n</p>\n<p>\n     --Down 21.73% at today's intraday low; largest intraday percent decrease since April 5, 2022, when it fell as much as 37.42% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 2:34:32 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 03, 2025 14:36 ET (19:36 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2580242862","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2580242862","pubTimestamp":1762198560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Enliven Therapeutics, Inc.  is currently at $19.27, down $4.15 or 17.72%. --Would be lowest close since Sept. 25, 2025, when it closed at $18.57. --On pace for largest percent decrease since April 5, 2022, when it fell 22.09%. --Currently down two consecutive days; down 19.61% over this period. --Down 14.36% year-to-date; on pace for worst year since 2023, when it fell 15.4%. --Down 91.22% from its all-time closing high of $219.48 on June 11, 2020. --Down 30.31% from 52 weeks ago , when it closed at $27.65. --Up 29.24% from its 52-week closing low of $14.91 on April 10, 2025. --Traded as low as $18.33; lowest intraday level since Sept. 26, 2025, when it hit $18.28. --Down 21.73% at today's intraday low; largest intraday percent decrease since April 5, 2022, when it fell as much as 37.42%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4007":"制药","ELVN":"Enliven Treateutics","BK4539":"次新股","LENZ":"Therapeutics"},"translate_title":"Enliven Therapeutics下跌近18%，创2022年4月以来最大跌幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1.5,"ELVN":1},"content_text":"Enliven Therapeutics, Inc. $(ELVN)$ is currently at $19.27, down $4.15 or 17.72% \n\n\n \n\n\n     --Would be lowest close since Sept. 25, 2025, when it closed at $18.57 \n\n\n     --On pace for largest percent decrease since April 5, 2022, when it fell 22.09% \n\n\n     --Currently down two consecutive days; down 19.61% over this period \n\n\n     --Worst two-day stretch since the two days ending April 6, 2022, when it fell 31.29% \n\n\n     --Down 14.36% year-to-date; on pace for worst year since 2023, when it fell 15.4% \n\n\n     --Down 91.22% from its all-time closing high of $219.48 on June 11, 2020 \n\n\n     --Down 30.31% from 52 weeks ago (Nov. 4, 2024), when it closed at $27.65 \n\n\n     --Down 34.79% from its 52-week closing high of $29.55 on Nov. 6, 2024 \n\n\n     --Up 29.24% from its 52-week closing low of $14.91 on April 10, 2025 \n\n\n     --Traded as low as $18.33; lowest intraday level since Sept. 26, 2025, when it hit $18.28 \n\n\n     --Down 21.73% at today's intraday low; largest intraday percent decrease since April 5, 2022, when it fell as much as 37.42% \n\n\n \n\n\n     All data as of 2:34:32 PM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 03, 2025 14:36 ET (19:36 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2580242862","isCrawlerRequest":true}